問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Principal Investigator
白禮源
下載
2021-08-01 - 2026-03-31
Condition/Disease
Test Drug
Participate Sites5Sites
Recruiting5Sites
2016-05-01 - 2020-12-31
Biliary Tract Cancer
Merestinib and Ramucirumab
Participate Sites6Sites
Terminated5Sites
未分科
Division of Hematology & Oncology
2021-03-05 - 2026-12-31
Participate Sites8Sites
Recruiting8Sites
2025-07-15 - 2028-08-21
Participate Sites3Sites
Recruiting3Sites
2023-04-01 - 2026-08-30
Malignant Solid Tumors
liquid
Participate Sites7Sites
Recruiting7Sites
2020-05-18 - 2023-12-31
Participate Sites4Sites
Terminated4Sites
2021-11-02 - 2025-06-13
2022-11-15 - 2025-02-15
Terminated3Sites
2021-03-15 - 2024-10-31
Recruiting4Sites
Terminated2Sites
2022-06-01 - 2024-10-31
全部
